Skip to main content
Erschienen in: Lung 4/2010

01.08.2010

Nontuberculous Mycobacteria and the Lung: From Suspicion to Treatment

verfasst von: Emmet E. McGrath, Zoe Blades, Josie McCabe, Hannah Jarry, Paul B. Anderson

Erschienen in: Lung | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Nontuberculous mycobacteria (NTM) are resilient bacteria that grow in virtually any environment, especially those where competing microorganisms are destroyed, such as in chlorinated water. They have been discovered in soil, dust, food, water, and domestic and wild animals. Nontuberculous mycobacteria tend to infect individuals with local (e.g., damaged skin or lung) or systemic (e.g., HIV, drugs, malignancy) defects in host defence, and their incidence and prevalence have consistently increased in the last decade. Difficulty may arise in determining whether an isolated NTM from a microbiological sample is in fact a contaminant or a pathogenic organism. In this review, we discuss the important mycobacteria involved in lung disease, factors that predispose individuals to infection, and their diagnosis and treatment according to updated guidelines. English language publications in MEDLINE and references from relevant articles from January 1, 1990 to June 28, 2009 were reviewed. Keywords searched were “nontuberculous,” “mycobacteria,” “diagnosis,” and “treatment.”
Literatur
1.
Zurück zum Zitat Piersimoni C, Scarparo C (2004) Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 8(5):323–334CrossRef Piersimoni C, Scarparo C (2004) Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis 8(5):323–334CrossRef
2.
Zurück zum Zitat Herdman AV, Steele JC Jr (2004) The new mycobacterial species—emerging or newly distinguished pathogens. Clin Lab Med 24(3):651–690, viPubMedCrossRef Herdman AV, Steele JC Jr (2004) The new mycobacterial species—emerging or newly distinguished pathogens. Clin Lab Med 24(3):651–690, viPubMedCrossRef
3.
Zurück zum Zitat Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K, ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367–416PubMedCrossRef
4.
Zurück zum Zitat Crow HE, King CT, Smith CE, Corpe RF, Stergus I (1957) A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc 75(2):199–222PubMed Crow HE, King CT, Smith CE, Corpe RF, Stergus I (1957) A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc 75(2):199–222PubMed
5.
Zurück zum Zitat McGrath EE, Anderson PB (2007) Increased prevalence of non-tuberculous mycobacteria infection. Lancet 370(9581):28PubMedCrossRef McGrath EE, Anderson PB (2007) Increased prevalence of non-tuberculous mycobacteria infection. Lancet 370(9581):28PubMedCrossRef
6.
Zurück zum Zitat Field SK, Cowie RL (2006) Lung disease due to the more common nontuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef Field SK, Cowie RL (2006) Lung disease due to the more common nontuberculous mycobacteria. Chest 129(6):1653–1672PubMedCrossRef
7.
Zurück zum Zitat Gubler JG, Salfinger M, von Graevenitz A (1992) Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest 101(5):1245–1249PubMedCrossRef Gubler JG, Salfinger M, von Graevenitz A (1992) Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest 101(5):1245–1249PubMedCrossRef
8.
Zurück zum Zitat Runyon EH (1959) Anonymous mycobacteria in pulmonary disease. Med Clin North Am 43(1):273–290PubMed Runyon EH (1959) Anonymous mycobacteria in pulmonary disease. Med Clin North Am 43(1):273–290PubMed
9.
Zurück zum Zitat Tortoli E (2003) Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990 s. Clin Microbiol Rev 16(2):319–354PubMedCrossRef Tortoli E (2003) Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990 s. Clin Microbiol Rev 16(2):319–354PubMedCrossRef
10.
11.
Zurück zum Zitat Inderlied CB, Kemper CA, Bermudez LE (1993) The Mycobacterium avium complex. Clin Microbiol Rev 6(3):266–310PubMed Inderlied CB, Kemper CA, Bermudez LE (1993) The Mycobacterium avium complex. Clin Microbiol Rev 6(3):266–310PubMed
12.
Zurück zum Zitat Falkinham JO III (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9(2):177–215PubMed Falkinham JO III (1996) Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 9(2):177–215PubMed
13.
Zurück zum Zitat Sugita Y, Ishii N, Katsuno M, Yamada R, Nakajima H (2000) Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system. Br J Dermatol 142(4):789–793PubMedCrossRef Sugita Y, Ishii N, Katsuno M, Yamada R, Nakajima H (2000) Familial cluster of cutaneous Mycobacterium avium infection resulting from use of a circulating, constantly heated bath water system. Br J Dermatol 142(4):789–793PubMedCrossRef
14.
Zurück zum Zitat Thomsen VO, Andersen AB, Miorner H (2002) Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 34(9):648–653PubMedCrossRef Thomsen VO, Andersen AB, Miorner H (2002) Incidence and clinical significance of non-tuberculous mycobacteria isolated from clinical specimens during a 2-y nationwide survey. Scand J Infect Dis 34(9):648–653PubMedCrossRef
15.
Zurück zum Zitat Haverkort F (2003) National atypical mycobacteria survey, 2000. Commun Dis Intell 27(2):180–189PubMed Haverkort F (2003) National atypical mycobacteria survey, 2000. Commun Dis Intell 27(2):180–189PubMed
16.
Zurück zum Zitat Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Köksalan K, Pereira MF, Rodrigues F, Pfyffer GE, Portaels F, Urgell JR, Rüsch-Gerdes S, Tortoli E, Vincent V, Watt B, Spanish Group for Non-Tuberculosis Mycobacteria (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed Martin-Casabona N, Bahrmand AR, Bennedsen J, Thomsen VO, Curcio M, Fauville-Dufaux M, Feldman K, Havelkova M, Katila ML, Köksalan K, Pereira MF, Rodrigues F, Pfyffer GE, Portaels F, Urgell JR, Rüsch-Gerdes S, Tortoli E, Vincent V, Watt B, Spanish Group for Non-Tuberculosis Mycobacteria (2004) Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey. Int J Tuberc Lung Dis 8(10):1186–1193PubMed
17.
Zurück zum Zitat Crump JA, van Ingen J, Morrissey AB, Boeree MJ, Mavura DR, Swai B, Thielman NM, Bartlett JA, Grossman H, Maro VP, van Soolingen D (2009) Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 15(1):53–55PubMedCrossRef Crump JA, van Ingen J, Morrissey AB, Boeree MJ, Mavura DR, Swai B, Thielman NM, Bartlett JA, Grossman H, Maro VP, van Soolingen D (2009) Invasive disease caused by nontuberculous mycobacteria, Tanzania. Emerg Infect Dis 15(1):53–55PubMedCrossRef
18.
Zurück zum Zitat Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed Obayashi Y, Fujita J, Suemitsu I, Kamei T, Nii M, Takahara J (1998) Clinical features of non-tuberculous mycobacterial disease: comparisons between smear-positive and smear-negative cases, and between Mycobacterium avium and Mycobacterium intracellulare. Int J Tuberc Lung Dis 2(7):597–602PubMed
19.
Zurück zum Zitat Reich JM, Johnson RE (1992) Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 101(6):1605–1609PubMedCrossRef Reich JM, Johnson RE (1992) Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 101(6):1605–1609PubMedCrossRef
20.
Zurück zum Zitat Embil J, Warren P, Yakrus M, Stark R, Corne S, Forrest D, Hershfield E (1997) Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection? Chest 111(3):813–816PubMedCrossRef Embil J, Warren P, Yakrus M, Stark R, Corne S, Forrest D, Hershfield E (1997) Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection? Chest 111(3):813–816PubMedCrossRef
21.
Zurück zum Zitat Kahana LM, Kay JM, Yakrus MA, Waserman S (1997) Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure. Chest 111(1):242–245PubMedCrossRef Kahana LM, Kay JM, Yakrus MA, Waserman S (1997) Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure. Chest 111(1):242–245PubMedCrossRef
22.
Zurück zum Zitat Cappelluti E, Fraire AE, Schaefer OP (2001) A case of “hot tub lung” due to Mycobacterium avium complex in an immunocompetent host. Arch Intern Med 163(7):845–848CrossRef Cappelluti E, Fraire AE, Schaefer OP (2001) A case of “hot tub lung” due to Mycobacterium avium complex in an immunocompetent host. Arch Intern Med 163(7):845–848CrossRef
23.
Zurück zum Zitat Tanaka D, Niwatsukino H, Oyama T, Nakajo M (2001) Progressing features of atypical mycobacterial infection in the lung on conventional and high resolution CT (HRCT) images. Radiat Med 19(5):237–245PubMed Tanaka D, Niwatsukino H, Oyama T, Nakajo M (2001) Progressing features of atypical mycobacterial infection in the lung on conventional and high resolution CT (HRCT) images. Radiat Med 19(5):237–245PubMed
24.
Zurück zum Zitat Mdluli K, Swanson J, Fischer E, Lee RE, Barry CE III (1998) Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 27(6):1223–1233PubMedCrossRef Mdluli K, Swanson J, Fischer E, Lee RE, Barry CE III (1998) Mechanisms involved in the intrinsic isoniazid resistance of Mycobacterium avium. Mol Microbiol 27(6):1223–1233PubMedCrossRef
25.
Zurück zum Zitat Bittner MJ, Horowitz EA, Safranek TJ, Preheim LC (1996) Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs hospital. Clin Infect Dis 22(6):1109–1110PubMed Bittner MJ, Horowitz EA, Safranek TJ, Preheim LC (1996) Emergence of Mycobacterium kansasii as the leading mycobacterial pathogen isolated over a 20-year period at a midwestern Veterans Affairs hospital. Clin Infect Dis 22(6):1109–1110PubMed
26.
Zurück zum Zitat Churchyard GJ, Kleinschmidt I, Corbett EL, Mulder D, De Cock KM (1999) Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis 3(9):791–798PubMed Churchyard GJ, Kleinschmidt I, Corbett EL, Mulder D, De Cock KM (1999) Mycobacterial disease in South African gold miners in the era of HIV infection. Int J Tuberc Lung Dis 3(9):791–798PubMed
27.
Zurück zum Zitat Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM (1999) Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 160(1):15–21PubMed Corbett EL, Blumberg L, Churchyard GJ, Moloi N, Mallory K, Clayton T, Williams BG, Chaisson RE, Hayes RJ, De Cock KM (1999) Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 160(1):15–21PubMed
28.
Zurück zum Zitat Corbett EL, Churchyard GJ, Hay M, Herselman P, Clayton T, Williams B, Hayes R, Mulder D, De Cock KM (1999) The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 160(1):10–14PubMed Corbett EL, Churchyard GJ, Hay M, Herselman P, Clayton T, Williams B, Hayes R, Mulder D, De Cock KM (1999) The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 160(1):10–14PubMed
29.
Zurück zum Zitat Corbett EL, Churchyard GJ, Clayton T, Herselman P, Williams B, Hayes R, Mulder D, De Cock KM (1999) Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med 159(1):94–99PubMed Corbett EL, Churchyard GJ, Clayton T, Herselman P, Williams B, Hayes R, Mulder D, De Cock KM (1999) Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med 159(1):94–99PubMed
30.
Zurück zum Zitat Corbett EL, Hay M, Churchyard GJ, Herselman P, Clayton T, Williams BG, Hayes R, Mulder D, De Cock KM (1999) Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 3(6):501–507PubMed Corbett EL, Hay M, Churchyard GJ, Herselman P, Clayton T, Williams BG, Hayes R, Mulder D, De Cock KM (1999) Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 3(6):501–507PubMed
31.
Zurück zum Zitat Taillard C, Greub G, Weber R, Pfyffer GE, Bodmer T, Zimmerli S, Frei R, Bassetti S, Rohner P, Piffaretti JC, Bernasconi E, Bille J, Telenti A, Prod’hom G (2003) Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol 41(3):1240–1244PubMedCrossRef Taillard C, Greub G, Weber R, Pfyffer GE, Bodmer T, Zimmerli S, Frei R, Bassetti S, Rohner P, Piffaretti JC, Bernasconi E, Bille J, Telenti A, Prod’hom G (2003) Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol 41(3):1240–1244PubMedCrossRef
32.
Zurück zum Zitat Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA (1979) A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 75(2):120–125PubMedCrossRef Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA (1979) A demographic study of disease due to Mycobacterium kansasii or M. intracellulare-avium in Texas. Chest 75(2):120–125PubMedCrossRef
33.
Zurück zum Zitat Smith MB, Molina CP, Schnadig VJ, Boyars MC, Aronson JF (2003) Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 127(5):554–560PubMed Smith MB, Molina CP, Schnadig VJ, Boyars MC, Aronson JF (2003) Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 127(5):554–560PubMed
34.
Zurück zum Zitat Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38(10):1428–1439PubMedCrossRef Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38(10):1428–1439PubMedCrossRef
35.
Zurück zum Zitat Francis PB, Jay SJ, Johanson WG Jr (1975) The course of untreated Mycobacterium kansasii disease. Am Rev Respir Dis 111(4):477–487PubMed Francis PB, Jay SJ, Johanson WG Jr (1975) The course of untreated Mycobacterium kansasii disease. Am Rev Respir Dis 111(4):477–487PubMed
36.
Zurück zum Zitat Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Hurst GA (1979) Pulmonary manifestations of Mycobacterium intracellularis. AJR Am J Roentgenol 133(1):59–66PubMed Christensen EE, Dietz GW, Ahn CH, Chapman JS, Murry RC, Hurst GA (1979) Pulmonary manifestations of Mycobacterium intracellularis. AJR Am J Roentgenol 133(1):59–66PubMed
37.
Zurück zum Zitat Lillo M, Orengo S, Cernoch P, Harris RL (1990) Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 12(5):760–767PubMed Lillo M, Orengo S, Cernoch P, Harris RL (1990) Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 12(5):760–767PubMed
38.
Zurück zum Zitat Buchholz UT, McNeil MM, Keyes LE, Good RC (1998) Mycobacterium malmoense infections in the United States, January 1993 through June 1995. Clin Infect Dis 27(3):551–558PubMedCrossRef Buchholz UT, McNeil MM, Keyes LE, Good RC (1998) Mycobacterium malmoense infections in the United States, January 1993 through June 1995. Clin Infect Dis 27(3):551–558PubMedCrossRef
39.
Zurück zum Zitat Research Committee of the British Thoracic Society (2001) First randomised trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense, and M. xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 56(3):167–172CrossRef Research Committee of the British Thoracic Society (2001) First randomised trial of treatments for pulmonary disease caused by M. avium intracellulare, M. malmoense, and M. xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 56(3):167–172CrossRef
40.
Zurück zum Zitat [No authors listed] (2003) Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment. Eur Respir J 21(3):478-482 [No authors listed] (2003) Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment. Eur Respir J 21(3):478-482
41.
Zurück zum Zitat Fakih M, Chapalamadugu S, Ricart A, Corriere N, Amsterdam D (1996) Mycobacterium malmoense bacteremia in two AIDS patients. J Clin Microbiol 34(3):731–733PubMed Fakih M, Chapalamadugu S, Ricart A, Corriere N, Amsterdam D (1996) Mycobacterium malmoense bacteremia in two AIDS patients. J Clin Microbiol 34(3):731–733PubMed
42.
Zurück zum Zitat Evans AJ, Crisp AJ, Colville A, Evans SA, Johnston ID (1993) Pulmonary infections caused by Mycobacterium malmoense and Mycobacterium tuberculosis: comparison of radiographic features. AJR Am J Roentgenol 161(4):733–737PubMed Evans AJ, Crisp AJ, Colville A, Evans SA, Johnston ID (1993) Pulmonary infections caused by Mycobacterium malmoense and Mycobacterium tuberculosis: comparison of radiographic features. AJR Am J Roentgenol 161(4):733–737PubMed
43.
Zurück zum Zitat Hoefsloot W, van Ingen J, de Lange WC, Dekhuijzen PN, Boeree MJ, van Soolingen D (2009) Clinical relevance of Mycobacterium malmoense isolation in The Netherlands. Eur Respir J 34(4):926–931PubMedCrossRef Hoefsloot W, van Ingen J, de Lange WC, Dekhuijzen PN, Boeree MJ, van Soolingen D (2009) Clinical relevance of Mycobacterium malmoense isolation in The Netherlands. Eur Respir J 34(4):926–931PubMedCrossRef
44.
Zurück zum Zitat Wallace RJ Jr, Brown BA, Griffith DE (1998) Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 52:453–490PubMedCrossRef Wallace RJ Jr, Brown BA, Griffith DE (1998) Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 52:453–490PubMedCrossRef
45.
Zurück zum Zitat Simor AE, Salit IE, Vellend H (1984) The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis 129(3):435–438PubMed Simor AE, Salit IE, Vellend H (1984) The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis 129(3):435–438PubMed
46.
Zurück zum Zitat Jenkins PA, Campbell IA (2003) Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 97(4):439–444PubMedCrossRef Jenkins PA, Campbell IA (2003) Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 97(4):439–444PubMedCrossRef
47.
Zurück zum Zitat Marusić A, Katalinić-Janković V, Popović-Grle S, Janković M, Mazuranić I, Puljić I, Sertić Milić H (2009) Mycobacterium xenopi pulmonary disease—epidemiology and clinical features in non-immunocompromised patients. J Infect 58(2):108–112PubMedCrossRef Marusić A, Katalinić-Janković V, Popović-Grle S, Janković M, Mazuranić I, Puljić I, Sertić Milić H (2009) Mycobacterium xenopi pulmonary disease—epidemiology and clinical features in non-immunocompromised patients. J Infect 58(2):108–112PubMedCrossRef
48.
Zurück zum Zitat Marks J, Jenkins PA, Tsukamura M (1972) Mycobacterium szulgai—a new pathogen. Tubercle 53(3):210–214PubMedCrossRef Marks J, Jenkins PA, Tsukamura M (1972) Mycobacterium szulgai—a new pathogen. Tubercle 53(3):210–214PubMedCrossRef
49.
Zurück zum Zitat van Ingen J, Boeree MJ, de Lange WC, de Haas PE, Dekhuijzen PN, van Soolingen D (2008) Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis 46(8):1200–1205PubMedCrossRef van Ingen J, Boeree MJ, de Lange WC, de Haas PE, Dekhuijzen PN, van Soolingen D (2008) Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis 46(8):1200–1205PubMedCrossRef
50.
Zurück zum Zitat Tortoli E, Besozzi G, Lacchini C, Penati V, Simonetti MT, Emler S (1998) Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature. Eur Respir J 11(4):975–977PubMedCrossRef Tortoli E, Besozzi G, Lacchini C, Penati V, Simonetti MT, Emler S (1998) Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature. Eur Respir J 11(4):975–977PubMedCrossRef
51.
Zurück zum Zitat Wolinsky E (1995) Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 20(4):954–963PubMed Wolinsky E (1995) Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 20(4):954–963PubMed
52.
Zurück zum Zitat Emori M, Kajiki A, Ikedo Y, Ochiai S, Iwata Y, Harada Y, Kitahara Y (2007) 15 cases of pulmonary Mycobacterium scrofulaceum infection. Kekkaku 82(3):173–178PubMed Emori M, Kajiki A, Ikedo Y, Ochiai S, Iwata Y, Harada Y, Kitahara Y (2007) 15 cases of pulmonary Mycobacterium scrofulaceum infection. Kekkaku 82(3):173–178PubMed
53.
Zurück zum Zitat Hawkins JE (1977) Scotochromogenic mycobacteria which appear intermediate between Mycobacterium avium-intracellulare and Mycobacterium scrofulaceum. Am Rev Respir Dis 116(5):963–964PubMed Hawkins JE (1977) Scotochromogenic mycobacteria which appear intermediate between Mycobacterium avium-intracellulare and Mycobacterium scrofulaceum. Am Rev Respir Dis 116(5):963–964PubMed
54.
Zurück zum Zitat Rynkiewicz DL, Cage GD, Butler WR, Ampel NM (1998) Clinical and microbiological assessment of Mycobacterium simiae isolates from a single laboratory in southern Arizona. Clin Infect Dis 26(3):625–630PubMedCrossRef Rynkiewicz DL, Cage GD, Butler WR, Ampel NM (1998) Clinical and microbiological assessment of Mycobacterium simiae isolates from a single laboratory in southern Arizona. Clin Infect Dis 26(3):625–630PubMedCrossRef
55.
Zurück zum Zitat Weiszfeiler JG, Karasseva V, Karczag E (1981) Mycobacterium simiae and related mycobacteria. Rev Infect Dis 3(5):1040–1045PubMed Weiszfeiler JG, Karasseva V, Karczag E (1981) Mycobacterium simiae and related mycobacteria. Rev Infect Dis 3(5):1040–1045PubMed
56.
Zurück zum Zitat Levy-Frebault V, Pangon B, Buré A, Katlama C, Marche C, David HL (1987) Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol 25(1):154–157PubMed Levy-Frebault V, Pangon B, Buré A, Katlama C, Marche C, David HL (1987) Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol 25(1):154–157PubMed
57.
Zurück zum Zitat Peters M, Schürmann D, Mayr AC, Heterzer R, Pohle HD, Ruf B (1989) Immunosuppression and mycobacteria other than Mycobacterium tuberculosis: results from patients with and without HIV infection. Epidemiol Infect 103(2):293–300PubMedCrossRef Peters M, Schürmann D, Mayr AC, Heterzer R, Pohle HD, Ruf B (1989) Immunosuppression and mycobacteria other than Mycobacterium tuberculosis: results from patients with and without HIV infection. Epidemiol Infect 103(2):293–300PubMedCrossRef
58.
Zurück zum Zitat Sriyabhaya N, Wongwatana S (1981) Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand. Rev Infect Dis 3(5):1085–1089PubMed Sriyabhaya N, Wongwatana S (1981) Pulmonary infection caused by atypical mycobacteria: a report of 24 cases in Thailand. Rev Infect Dis 3(5):1085–1089PubMed
59.
Zurück zum Zitat El Sahly HM, Septimus E, Soini H, Septimus J, Wallace RJ, Pan X, Williams-Bouyer N, Musser JM, Graviss EA (2002) Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 35(7):802–807PubMedCrossRef El Sahly HM, Septimus E, Soini H, Septimus J, Wallace RJ, Pan X, Williams-Bouyer N, Musser JM, Graviss EA (2002) Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 35(7):802–807PubMedCrossRef
60.
Zurück zum Zitat Conger NG, O’Connell RJ, Laurel VL, Olivier KN, Graviss EA, Williams-Bouyer N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr (2004) Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 25(12):1050–1055PubMedCrossRef Conger NG, O’Connell RJ, Laurel VL, Olivier KN, Graviss EA, Williams-Bouyer N, Zhang Y, Brown-Elliott BA, Wallace RJ Jr (2004) Mycobacterium simae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 25(12):1050–1055PubMedCrossRef
61.
Zurück zum Zitat Porteous NB, Redding SW, Jorgensen JH (2004) Isolation of non-tuberculosis mycobacteria in treated dental unit waterlines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):40–44PubMedCrossRef Porteous NB, Redding SW, Jorgensen JH (2004) Isolation of non-tuberculosis mycobacteria in treated dental unit waterlines. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):40–44PubMedCrossRef
62.
Zurück zum Zitat Maoz C, Shitrit D, Samra Z, Peled N, Kaufman L, Kramer MR, Bishara J (2008) Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 27(10):945–950PubMedCrossRef Maoz C, Shitrit D, Samra Z, Peled N, Kaufman L, Kramer MR, Bishara J (2008) Pulmonary Mycobacterium simiae infection: comparison with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis 27(10):945–950PubMedCrossRef
63.
64.
Zurück zum Zitat De Groote MA, Huitt G (2006) Infections due to rapidly growing mycobacteria. Clin Infect Dis 42(12):1756–1763PubMedCrossRef De Groote MA, Huitt G (2006) Infections due to rapidly growing mycobacteria. Clin Infect Dis 42(12):1756–1763PubMedCrossRef
65.
Zurück zum Zitat Griffith DE, Girard WM, Wallace RJ Jr (1993) Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147(5):1271–1278PubMed Griffith DE, Girard WM, Wallace RJ Jr (1993) Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147(5):1271–1278PubMed
66.
Zurück zum Zitat Han XY, De I, Jacobson KL (2007) Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 128(4):612–621PubMedCrossRef Han XY, De I, Jacobson KL (2007) Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 128(4):612–621PubMedCrossRef
67.
Zurück zum Zitat Phowthongkum P, Prasanthai V, Udomsantisook N, Suankratay C (2005) Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand. J Med Assoc Thai 88(8):1153–1162PubMed Phowthongkum P, Prasanthai V, Udomsantisook N, Suankratay C (2005) Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand. J Med Assoc Thai 88(8):1153–1162PubMed
68.
Zurück zum Zitat Daley CL, Griffith DE (2002) Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 23(3):623–632, viiPubMedCrossRef Daley CL, Griffith DE (2002) Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 23(3):623–632, viiPubMedCrossRef
69.
Zurück zum Zitat Hadjiliadis D, Adlakha A, Prakash UB (1999) Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc 74(1):45–51PubMedCrossRef Hadjiliadis D, Adlakha A, Prakash UB (1999) Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc 74(1):45–51PubMedCrossRef
70.
Zurück zum Zitat Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167(6):828–834PubMedCrossRef Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group (2003) Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167(6):828–834PubMedCrossRef
71.
Zurück zum Zitat Pomerantz M, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group (1991) Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 52(5):1108–1111 discussion 1112PubMed Pomerantz M, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, Edwards LJ, Chakraborti S, Knowles MR, Nontuberculous Mycobacteria in Cystic Fibrosis Study Group (1991) Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 52(5):1108–1111 discussion 1112PubMed
72.
Zurück zum Zitat Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N (2004) Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg 78(2):399–403PubMedCrossRef Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N (2004) Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg 78(2):399–403PubMedCrossRef
73.
Zurück zum Zitat Jacobson K, Garcia R, Libshitz H, Whimbey E, Rolston K, Abi-Said D, Raad I (1998) Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients. Eur J Clin Microbiol Infect Dis 17(9):615–621PubMed Jacobson K, Garcia R, Libshitz H, Whimbey E, Rolston K, Abi-Said D, Raad I (1998) Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients. Eur J Clin Microbiol Infect Dis 17(9):615–621PubMed
74.
Zurück zum Zitat Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr (2005) Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 55(2):170–177PubMedCrossRef Nash KA, Zhang Y, Brown-Elliott BA, Wallace RJ Jr (2005) Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother 55(2):170–177PubMedCrossRef
75.
Zurück zum Zitat Nash KA, Brown-Elliott BA, Wallace RJ Jr (2009) A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53(4):1367–1376PubMedCrossRef Nash KA, Brown-Elliott BA, Wallace RJ Jr (2009) A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53(4):1367–1376PubMedCrossRef
76.
Zurück zum Zitat Nomura K, Ogawa M, Miyamoto H, Muratani T, Taniguchi H (2004) Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines. Am J Infect Control 32(4):185–188PubMedCrossRef Nomura K, Ogawa M, Miyamoto H, Muratani T, Taniguchi H (2004) Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines. Am J Infect Control 32(4):185–188PubMedCrossRef
77.
Zurück zum Zitat Hsieh HC, Lu PL, Chen TC, Chang K, Chen YH (2008) Mycobacterium chelonae empyema in an immunocompetent patient. J Med Microbiol 57(Pt 5):664–667PubMedCrossRef Hsieh HC, Lu PL, Chen TC, Chang K, Chen YH (2008) Mycobacterium chelonae empyema in an immunocompetent patient. J Med Microbiol 57(Pt 5):664–667PubMedCrossRef
78.
Zurück zum Zitat Hazelton TR, Newell JD Jr, Cook JL, Huitt GA, Lynch DA (2000) CT findings in 14 patients with Mycobacterium chelonae pulmonary infection. AJR Am J Roentgenol 175(2):413–416PubMed Hazelton TR, Newell JD Jr, Cook JL, Huitt GA, Lynch DA (2000) CT findings in 14 patients with Mycobacterium chelonae pulmonary infection. AJR Am J Roentgenol 175(2):413–416PubMed
79.
Zurück zum Zitat Wallace RJ Jr, Brown BA, Onyi GO (1992) Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166(2):405–412PubMed Wallace RJ Jr, Brown BA, Onyi GO (1992) Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166(2):405–412PubMed
80.
Zurück zum Zitat Brown-Elliott BA, Wallace RJ Jr (2002) Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15(4):716–746PubMedCrossRef Brown-Elliott BA, Wallace RJ Jr (2002) Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15(4):716–746PubMedCrossRef
81.
Zurück zum Zitat Fowler SJ, French J, Screaton NJ, Foweraker J, Condliffe A, Haworth CS, Exley AR, Bilton D (2006) Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 28(6):1204–1210PubMedCrossRef Fowler SJ, French J, Screaton NJ, Foweraker J, Condliffe A, Haworth CS, Exley AR, Bilton D (2006) Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 28(6):1204–1210PubMedCrossRef
82.
Zurück zum Zitat Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV, Abdallah S, Shah P, Wilson R (2005) Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60(12):1045–1051PubMedCrossRef Wickremasinghe M, Ozerovitch LJ, Davies G, Wodehouse T, Chadwick MV, Abdallah S, Shah P, Wilson R (2005) Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 60(12):1045–1051PubMedCrossRef
83.
Zurück zum Zitat Esther CR Jr, Henry MM, Molina PL, Leigh MW (2005) Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 40(1):39–44PubMedCrossRef Esther CR Jr, Henry MM, Molina PL, Leigh MW (2005) Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 40(1):39–44PubMedCrossRef
84.
Zurück zum Zitat Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, Fauroux B, Mariani P, Munck A, Bingen E, Guillemot D, Quesne G, Vincent V, Berche P, Gaillard JL (2005) Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43(7):3467–3470PubMedCrossRef Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, Fauroux B, Mariani P, Munck A, Bingen E, Guillemot D, Quesne G, Vincent V, Berche P, Gaillard JL (2005) Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 43(7):3467–3470PubMedCrossRef
85.
Zurück zum Zitat Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H (2005) Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 25(2):324–328PubMedCrossRef Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H (2005) Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 25(2):324–328PubMedCrossRef
86.
Zurück zum Zitat Iseman MD, Buschman DL, Ackerson LM (1991) Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 144(4):914–916PubMed Iseman MD, Buschman DL, Ackerson LM (1991) Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 144(4):914–916PubMed
87.
Zurück zum Zitat Henry MT, Rivlin J, Shalit I, Ephros M, Blau H (2004) Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23(5):741–746PubMedCrossRef Henry MT, Rivlin J, Shalit I, Ephros M, Blau H (2004) Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response. Eur Respir J 23(5):741–746PubMedCrossRef
88.
Zurück zum Zitat McGrath EE, Bardsley P (2009) An association between Mycobacterium malmoense and coal workers’ pneumoconiosis. Lung 187(1):51–54PubMedCrossRef McGrath EE, Bardsley P (2009) An association between Mycobacterium malmoense and coal workers’ pneumoconiosis. Lung 187(1):51–54PubMedCrossRef
89.
Zurück zum Zitat Thomson RM, Armstrong JG, Looke DF (2007) Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease. Chest 131(4):1166–1172PubMedCrossRef Thomson RM, Armstrong JG, Looke DF (2007) Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease. Chest 131(4):1166–1172PubMedCrossRef
90.
Zurück zum Zitat Koh WJ, Lee JH, Kwon YS, Lee KS, Suh GY, Chung MP, Kim H, Kwon OJ (2007) Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest 131(6):1825–1830PubMedCrossRef Koh WJ, Lee JH, Kwon YS, Lee KS, Suh GY, Chung MP, Kim H, Kwon OJ (2007) Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest 131(6):1825–1830PubMedCrossRef
91.
Zurück zum Zitat Horsburgh CR Jr (1991) Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324(19):1332–1338PubMedCrossRef Horsburgh CR Jr (1991) Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 324(19):1332–1338PubMedCrossRef
92.
Zurück zum Zitat Jones D, Havlir DV (2002) Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med 23(3):665–674PubMedCrossRef Jones D, Havlir DV (2002) Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med 23(3):665–674PubMedCrossRef
93.
Zurück zum Zitat Hocqueloux L, Lesprit P, Herrmann JL, de La Blanchardiere A, Zagdanski AM, Decazes JM, Modai J (1998) Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. Chest 113(2):542–548PubMedCrossRef Hocqueloux L, Lesprit P, Herrmann JL, de La Blanchardiere A, Zagdanski AM, Decazes JM, Modai J (1998) Pulmonary Mycobacterium avium complex disease without dissemination in HIV-infected patients. Chest 113(2):542–548PubMedCrossRef
94.
Zurück zum Zitat Marras TK, Morris A, Gonzalez LC, Daley CL (2004) Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Am J Respir Crit Care Med 170(7):793–798PubMedCrossRef Marras TK, Morris A, Gonzalez LC, Daley CL (2004) Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Am J Respir Crit Care Med 170(7):793–798PubMedCrossRef
95.
Zurück zum Zitat Marras TK, Daley CK (2004) A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection. J Acquir Immune Defic Syndr 36(4):883–889PubMedCrossRef Marras TK, Daley CK (2004) A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection. J Acquir Immune Defic Syndr 36(4):883–889PubMedCrossRef
96.
Zurück zum Zitat Shelburne SA III, Hamill RJ (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5(2):67–79PubMed Shelburne SA III, Hamill RJ (2003) The immune reconstitution inflammatory syndrome. AIDS Rev 5(2):67–79PubMed
97.
Zurück zum Zitat Lawn SD, Bekker LG, Miller RF (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5(6):361–373PubMedCrossRef Lawn SD, Bekker LG, Miller RF (2005) Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5(6):361–373PubMedCrossRef
98.
Zurück zum Zitat Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O’Shaughnessy M, Montaner J (2005) Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 41(10):1483–1497PubMedCrossRef Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O’Shaughnessy M, Montaner J (2005) Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 41(10):1483–1497PubMedCrossRef
99.
Zurück zum Zitat Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002) Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81(3):213–227CrossRef Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002) Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81(3):213–227CrossRef
100.
Zurück zum Zitat Malouf MA, Glanville AR (1999) The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 160(5 Pt 1):1611–1616PubMed Malouf MA, Glanville AR (1999) The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 160(5 Pt 1):1611–1616PubMed
101.
Zurück zum Zitat Queipo JA, Broseta E, Santos M, Sánchez-Plumed J, Budía A, Jiménez-Cruz F (2003) Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 9(6):518–525PubMedCrossRef Queipo JA, Broseta E, Santos M, Sánchez-Plumed J, Budía A, Jiménez-Cruz F (2003) Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 9(6):518–525PubMedCrossRef
102.
Zurück zum Zitat Sexton P, Harrison AC (2008) Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31(6):1322–1333PubMedCrossRef Sexton P, Harrison AC (2008) Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31(6):1322–1333PubMedCrossRef
103.
Zurück zum Zitat Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E (2000) Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30(6):965–969PubMedCrossRef Jacobson KL, Teira R, Libshitz HI, Raad I, Rolston KV, Terrand J, Whimbey E (2000) Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30(6):965–969PubMedCrossRef
104.
Zurück zum Zitat Thaker H, Neilly IJ, Saunders PG, Magee JG, Snow MH, Ong EL (2001) Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect 42(3):213–214PubMedCrossRef Thaker H, Neilly IJ, Saunders PG, Magee JG, Snow MH, Ong EL (2001) Remember mycobacterial disease in hairy cell leukaemia (HCL). J Infect 42(3):213–214PubMedCrossRef
105.
Zurück zum Zitat Finucane K, Ambrey P, Narayan S, Archer CB, Dayan C (2003) Insulin injection abscesses caused by Mycobacterium chelonae. Diabetes Care 26(8):2483–2484PubMedCrossRef Finucane K, Ambrey P, Narayan S, Archer CB, Dayan C (2003) Insulin injection abscesses caused by Mycobacterium chelonae. Diabetes Care 26(8):2483–2484PubMedCrossRef
106.
Zurück zum Zitat Jackson PG, Keen H, Noble CJ, Simmons NA (1980) Injection abscesses in a diabetic due to Mycobacterium chelonei var abscessus. Br Med J 281(6248):1105–1106PubMedCrossRef Jackson PG, Keen H, Noble CJ, Simmons NA (1980) Injection abscesses in a diabetic due to Mycobacterium chelonei var abscessus. Br Med J 281(6248):1105–1106PubMedCrossRef
107.
Zurück zum Zitat Kelly SE (1987) Multiple injection abscesses in a diabetic caused by Mycobacterium chelonei. Clin Exp Dermatol 12(1):48–49PubMedCrossRef Kelly SE (1987) Multiple injection abscesses in a diabetic caused by Mycobacterium chelonei. Clin Exp Dermatol 12(1):48–49PubMedCrossRef
108.
Zurück zum Zitat Schadlow M, Laochumroonvorapong P, Burack L, Wu H, Sinha AA (2003) Nodules on the arm of a diabetic patient. Arch Dermatol 139(1):93–98PubMedCrossRef Schadlow M, Laochumroonvorapong P, Burack L, Wu H, Sinha AA (2003) Nodules on the arm of a diabetic patient. Arch Dermatol 139(1):93–98PubMedCrossRef
109.
Zurück zum Zitat Nagaia T, Akiyama M, Mita Y, Tomizawa T, Dobashi K, Mori M (2000) Mycobacterium avium complex pleuritis accompanied by diabetes mellitus. Diabetes Res Clin Pract 48(2):99–104PubMedCrossRef Nagaia T, Akiyama M, Mita Y, Tomizawa T, Dobashi K, Mori M (2000) Mycobacterium avium complex pleuritis accompanied by diabetes mellitus. Diabetes Res Clin Pract 48(2):99–104PubMedCrossRef
110.
Zurück zum Zitat Arend SM, Cerdá de Palou E, de Haas P, Janssen R, Hoeve MA, Verhard EM, Ottenhoff TH, van Soolingen D, van Dissel JT (2004) Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. Clin Microbiol Infect 10(8):738–748PubMedCrossRef Arend SM, Cerdá de Palou E, de Haas P, Janssen R, Hoeve MA, Verhard EM, Ottenhoff TH, van Soolingen D, van Dissel JT (2004) Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defect. Clin Microbiol Infect 10(8):738–748PubMedCrossRef
111.
Zurück zum Zitat Robillon JF, Sadoul JL, Guerin P, Iafrate-Lacoste C, Talbodec A, Santini J, Canivet B, Freychet P (1994) Mycobacterium avium intracellulare suppurative thyroiditis in a patient with Hashimoto’s thyroiditis. J Endocrinol Invest 17(2):133–134PubMed Robillon JF, Sadoul JL, Guerin P, Iafrate-Lacoste C, Talbodec A, Santini J, Canivet B, Freychet P (1994) Mycobacterium avium intracellulare suppurative thyroiditis in a patient with Hashimoto’s thyroiditis. J Endocrinol Invest 17(2):133–134PubMed
112.
Zurück zum Zitat Southern PM Jr (2004) Tenosynovitis caused by Mycobacterium kansasii associated with a dog bite. Am J Med Sci 327(5):258–261PubMedCrossRef Southern PM Jr (2004) Tenosynovitis caused by Mycobacterium kansasii associated with a dog bite. Am J Med Sci 327(5):258–261PubMedCrossRef
113.
Zurück zum Zitat Maimon N, Brunton J, Chan AK, Marras TK (2007) Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax 62(8):739–740PubMedCrossRef Maimon N, Brunton J, Chan AK, Marras TK (2007) Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept. Thorax 62(8):739–740PubMedCrossRef
114.
Zurück zum Zitat Thomas JE, Taoka CR, Gibbs BT, Fraser SL (2006) Fatal pulmonary Mycobacterium abscessus infection in a patient using etanercept. Hawaii Med J 65(1):12–15PubMed Thomas JE, Taoka CR, Gibbs BT, Fraser SL (2006) Fatal pulmonary Mycobacterium abscessus infection in a patient using etanercept. Hawaii Med J 65(1):12–15PubMed
115.
Zurück zum Zitat van Ingen J, Boeree M, Janssen M, Ullmann E, de Lange W, de Haas P, Dekhuijzen R, van Soolingen D (2007) Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy. Nat Clin Pract Rheumatol 3(7):414–419PubMedCrossRef van Ingen J, Boeree M, Janssen M, Ullmann E, de Lange W, de Haas P, Dekhuijzen R, van Soolingen D (2007) Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy. Nat Clin Pract Rheumatol 3(7):414–419PubMedCrossRef
116.
Zurück zum Zitat van de Vosse E, Hoeve MA, Ottenhoff TH (2004) Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4(12):739–749PubMedCrossRef van de Vosse E, Hoeve MA, Ottenhoff TH (2004) Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4(12):739–749PubMedCrossRef
117.
Zurück zum Zitat Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israël A, Courtois G, Casanova JL (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27(3):277–285PubMedCrossRef Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israël A, Courtois G, Casanova JL (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27(3):277–285PubMedCrossRef
118.
Zurück zum Zitat Ohga S, Ikeuchi K, Kadoya R, Okada K, Miyazaki C, Suita S, Ueda K (1997) Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease. J Infect 34(2):147–150PubMedCrossRef Ohga S, Ikeuchi K, Kadoya R, Okada K, Miyazaki C, Suita S, Ueda K (1997) Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease. J Infect 34(2):147–150PubMedCrossRef
119.
Zurück zum Zitat Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S (2000) Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 162(1):316–318PubMed Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S (2000) Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 162(1):316–318PubMed
120.
Zurück zum Zitat Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW (2005) NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128(1):94–101PubMedCrossRef Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW (2005) NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128(1):94–101PubMedCrossRef
121.
Zurück zum Zitat Ehrmantraut ME, Hilligoss DM, Chernick M, Steagall WK, Glasgow CG, Anderson VL (2003) Pulmonary nontuberculous mycobacterial infections are highly associated with mutations in CFTR. Am J Respir Crit Care Med 167:A708CrossRef Ehrmantraut ME, Hilligoss DM, Chernick M, Steagall WK, Glasgow CG, Anderson VL (2003) Pulmonary nontuberculous mycobacterial infections are highly associated with mutations in CFTR. Am J Respir Crit Care Med 167:A708CrossRef
122.
Zurück zum Zitat Ryu YJ, Kim EJ, Lee SH, Kim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ (2007) Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. Eur Respir J 30(4):736–742PubMedCrossRef Ryu YJ, Kim EJ, Lee SH, Kim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ (2007) Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease. Eur Respir J 30(4):736–742PubMedCrossRef
123.
Zurück zum Zitat Huang JH, Oefner PJ, Adi V, Ratnam K, Ruoss SJ, Trako E, Kao PN (1998) Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med 157(2):377–381PubMed Huang JH, Oefner PJ, Adi V, Ratnam K, Ruoss SJ, Trako E, Kao PN (1998) Analyses of the NRAMP1 and IFN-gammaR1 genes in women with Mycobacterium avium-intracellulare pulmonary disease. Am J Respir Crit Care Med 157(2):377–381PubMed
124.
Zurück zum Zitat Woods GL (2002) The mycobacteriology laboratory and new diagnostic techniques. Infect Dis Clin North Am 16(1):127–144PubMedCrossRef Woods GL (2002) The mycobacteriology laboratory and new diagnostic techniques. Infect Dis Clin North Am 16(1):127–144PubMedCrossRef
125.
Zurück zum Zitat Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC (1993) The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 31(4):767–770PubMed Tenover FC, Crawford JT, Huebner RE, Geiter LJ, Horsburgh CR Jr, Good RC (1993) The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol 31(4):767–770PubMed
126.
Zurück zum Zitat Glassroth J (2008) Pulmonary disease due to nontuberculous mycobacteria. Chest 133(1):243–251PubMedCrossRef Glassroth J (2008) Pulmonary disease due to nontuberculous mycobacteria. Chest 133(1):243–251PubMedCrossRef
127.
Zurück zum Zitat Wallace RJ Jr, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT (1994) Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 18(5):736–743PubMed Wallace RJ Jr, Dunbar D, Brown BA, Onyi G, Dunlap R, Ahn CH, Murphy DT (1994) Rifampin-resistant Mycobacterium kansasii. Clin Infect Dis 18(5):736–743PubMed
128.
Zurück zum Zitat Valero G, Peters J, Jorgensen JH, Graybill JR (1995) Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med 152(51):1555–1557PubMed Valero G, Peters J, Jorgensen JH, Graybill JR (1995) Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Am J Respir Crit Care Med 152(51):1555–1557PubMed
129.
Zurück zum Zitat Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, Maugein J, French Mycobacteria Study Group (2006) Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 28(6):1211–1215PubMedCrossRef Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, Maugein J, French Mycobacteria Study Group (2006) Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 28(6):1211–1215PubMedCrossRef
130.
Zurück zum Zitat van Ingen J, Boeree MJ, de Lange WC, Dekhuijzen PN, van Soolingen D (2007) Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection. Am J Respir Crit Care Med 176(4):418, author reply 419PubMed van Ingen J, Boeree MJ, de Lange WC, Dekhuijzen PN, van Soolingen D (2007) Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection. Am J Respir Crit Care Med 176(4):418, author reply 419PubMed
Metadaten
Titel
Nontuberculous Mycobacteria and the Lung: From Suspicion to Treatment
verfasst von
Emmet E. McGrath
Zoe Blades
Josie McCabe
Hannah Jarry
Paul B. Anderson
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 4/2010
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9240-9

Weitere Artikel der Ausgabe 4/2010

Lung 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.